Adjuvant therapy in breast cancer (original) (raw)
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy
Aysegul Sahin, Vicente Valero
International Journal of Radiation Oncology*Biology*Physics, 2002
View PDFchevron_right
Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy
Ernesto Kahan
Breast Cancer Research and Treatment, 1992
View PDFchevron_right
Pathological prognostic factors in breast cancer
Sarah Pinder
Critical Reviews in Oncology/Hematology, 1999
View PDFchevron_right
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999
Ann Thor
Archives of pathology & laboratory medicine, 2000
View PDFchevron_right
Changes in Invasive Breast Carcinomas after Neoadjuvant Chemotherapy Can Influence Adjuvant Therapeutic Decisions
Cristiana Nunes
Cancer Research and Treatment
View PDFchevron_right
Prognosis and Outcome of Small (<=1 cm), Node-Negative Breast Cancer on the Basis of Hormonal and HER-2 Status
Winston Tan
The Oncologist, 2010
View PDFchevron_right
Prognostic Factors for Breast Cancer Recurrence after Conservative Treatment
Souha Sahraoui
2022
View PDFchevron_right
A meta-analysis of reported correlations between prognostic factors in breast cancer: Does axillary lymph node metastasis represent biology or chronology?
Indraneel Mittra
European Journal of Cancer and Clinical Oncology, 1991
View PDFchevron_right
Positive axillary lymph node metastases in T1–T3 breast cancer: prognostic value of extracapsular extension
Sinisa Maksimovic
Breast Cancer Research, 2007
View PDFchevron_right
Size of Residual Lymph Node Metastasis After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients Is Prognostic
Benjamin F Calvo
Annals of Surgical Oncology, 2006
View PDFchevron_right
ARTICLES Prognosis and Treatment of Patients With Breast Tumors of One Centimeter or Less and Negative Axillary Lymph Nodes
James Wittliff
2001
View PDFchevron_right
Prognosis and Treatment of Patients With Breast Tumors of One Centimeter or Less and Negative Axillary Lymph Nodes
James Wittliff
Journal of the National Cancer Institute, 2001
View PDFchevron_right
American Joint Committee on Cancer Tumor-Node-Metastasis Stage After Neoadjuvant Chemotherapy and Breast Cancer Outcome
Lisa Carey
JNCI Journal of the National Cancer Institute, 2005
View PDFchevron_right
Early distant relapse in ?node-negative? breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour
Peter van Dam
The Journal of Pathology, 2001
View PDFchevron_right
Prognostic Factors in the Evaluation of Metastatic Breast Cancer
oana arghir
2008
View PDFchevron_right
Natural history of node-negative breast cancer: are conventional prognostic factors predictors of time to relapse?
Eric Teissier
The Breast, 2002
View PDFchevron_right
To Compare the Effects of Adjuvant and Neoadjuvant Chemotherapy on Outcome of Stage Iii Carcinoma Breast
IOSR Journals
View PDFchevron_right
Prognostic value of different factors in breast carcinoma
Borislav E Belev, Marijana Corić
Tumori, 2004
View PDFchevron_right
Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up
Emer Hanrahan
Annals of Oncology, 2002
View PDFchevron_right
The Prognostic Value of Axillary Lymph Node Ratio for Non- Metastatic Node Positive Breast Cancers
IOSR Journals
IOSR Journals , 2019
View PDFchevron_right
Identifying Good Prognosis Group of Breast Cancer Patients with 1-3 Positive Axillary Nodes for Adjuvant Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) Chemotherapy
Yung-chang Lin
Japanese Journal of Clinical Oncology, 2005
View PDFchevron_right
Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer
Irene Wapnir
Annals of Surgical Oncology, 2016
View PDFchevron_right
Prognostic factors in invasive carcinoma of the breast
Sarah Pinder
Clinical Oncology, 1998
View PDFchevron_right
Benefits of Neoadjuvant Chemotherapy for Luminal Breast Cancer with Respect to Tumor Response
Ali Aktekin
Journal of Oncological Sciences, 2021
View PDFchevron_right
Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response
Susana Ramalho
BMC Cancer, 2019
View PDFchevron_right
Predictors of Axillary Lymph Node Metastases in Patients with Invasive Breast Carcinoma by a Combination of Classical and Biological Prognostic Factors*
J. Fernando Val Bernal
Pathology - Research and Practice, 1999
View PDFchevron_right
The effect of tumor size and lymph node status on breast carcinoma lethality
Melvin Silverstein
Cancer, 2003
View PDFchevron_right
The analysis of prognostic factors in stage III-B non-inflammatory breast cancer
Emin Yildirim
European Journal of Surgical Oncology (EJSO), 2000
View PDFchevron_right
Adjuvant Chemotherapy of Breast Cancer
M. Gnant
Breast Care, 2009
View PDFchevron_right